Cargando…
Remote Prescription During Pandemic: Challenges and Solutions
The current COVID-19 pandemic has created an awareness and at the same time provides an impetus to transform digitalisation of healthcare delivery. Remote prescription is one key component of telemedicine, but it is the easiest and already practised in most places during the current pandemic even wi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc. on behalf of IMSS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825817/ https://www.ncbi.nlm.nih.gov/pubmed/33500154 http://dx.doi.org/10.1016/j.arcmed.2020.12.007 |
_version_ | 1783640396506595328 |
---|---|
author | Lim, Ee-Chien Chen, Celeste Yan-Teng Tan, Eng-King |
author_facet | Lim, Ee-Chien Chen, Celeste Yan-Teng Tan, Eng-King |
author_sort | Lim, Ee-Chien |
collection | PubMed |
description | The current COVID-19 pandemic has created an awareness and at the same time provides an impetus to transform digitalisation of healthcare delivery. Remote prescription is one key component of telemedicine, but it is the easiest and already practised in most places during the current pandemic even without the framework of virtual medicine in place. However, remote prescription, with its antecedent problems cannot be properly and safely executed in isolation. To ensure patients' safety and health outcomes, specific guidelines will need to be developed to cater for specific medical conditions to address individual drug prescriptions and concerns. There is a need for a robust governance to ensure that patient's safety is the foremost priority, and provisions should be made for requirements of remote prescription in the different medical subspecialities. The pandemic provides an enormous opportunity for stakeholders and policymakers to come together to create a seamless and user friendly and yet innovative healthcare ecosystem to transform clinical healthcare delivery with patient safety as the core driver in the implementation. |
format | Online Article Text |
id | pubmed-7825817 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Published by Elsevier Inc. on behalf of IMSS. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78258172021-01-25 Remote Prescription During Pandemic: Challenges and Solutions Lim, Ee-Chien Chen, Celeste Yan-Teng Tan, Eng-King Arch Med Res Opinion The current COVID-19 pandemic has created an awareness and at the same time provides an impetus to transform digitalisation of healthcare delivery. Remote prescription is one key component of telemedicine, but it is the easiest and already practised in most places during the current pandemic even without the framework of virtual medicine in place. However, remote prescription, with its antecedent problems cannot be properly and safely executed in isolation. To ensure patients' safety and health outcomes, specific guidelines will need to be developed to cater for specific medical conditions to address individual drug prescriptions and concerns. There is a need for a robust governance to ensure that patient's safety is the foremost priority, and provisions should be made for requirements of remote prescription in the different medical subspecialities. The pandemic provides an enormous opportunity for stakeholders and policymakers to come together to create a seamless and user friendly and yet innovative healthcare ecosystem to transform clinical healthcare delivery with patient safety as the core driver in the implementation. Published by Elsevier Inc. on behalf of IMSS. 2021-05 2021-01-23 /pmc/articles/PMC7825817/ /pubmed/33500154 http://dx.doi.org/10.1016/j.arcmed.2020.12.007 Text en © 2021 Published by Elsevier Inc. on behalf of IMSS. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Opinion Lim, Ee-Chien Chen, Celeste Yan-Teng Tan, Eng-King Remote Prescription During Pandemic: Challenges and Solutions |
title | Remote Prescription During Pandemic: Challenges and Solutions |
title_full | Remote Prescription During Pandemic: Challenges and Solutions |
title_fullStr | Remote Prescription During Pandemic: Challenges and Solutions |
title_full_unstemmed | Remote Prescription During Pandemic: Challenges and Solutions |
title_short | Remote Prescription During Pandemic: Challenges and Solutions |
title_sort | remote prescription during pandemic: challenges and solutions |
topic | Opinion |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7825817/ https://www.ncbi.nlm.nih.gov/pubmed/33500154 http://dx.doi.org/10.1016/j.arcmed.2020.12.007 |
work_keys_str_mv | AT limeechien remoteprescriptionduringpandemicchallengesandsolutions AT chencelesteyanteng remoteprescriptionduringpandemicchallengesandsolutions AT tanengking remoteprescriptionduringpandemicchallengesandsolutions |